B. Riley analyst Jeff Van Sinderen lowered the firm’s price target on Herbalife to $23 from $33 and keeps a Buy rating on the shares. Herbalife’s Q3 revenue was slightly above consensus, while AEBITDA was in line, the analyst tells investors in a research note. The firm cites multiple compression in the peer group and the softening consumer backdrop for the price target decrease.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HLF: